BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1113591)

  • 1. Optimal treatment for the technically resectable squamous cell carcinoma of the supraglottic larynx.
    Goepfert H; Jesse RH; Fletcher GH; Hamberger A
    Laryngoscope; 1975 Jan; 85(1):14-32. PubMed ID: 1113591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.
    Spector JG; Sessions DG; Emami B; Simpson J; Haughey B; Harvey J; Fredrickson JM
    Laryngoscope; 1995 Apr; 105(4 Pt 1):397-406. PubMed ID: 7715386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 57 patients with poorly differentiated carcinomas of the supraglottic larynx].
    Liu WS; Tang PZ; Qi YF; Xu ZG; Li ZJ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Sep; 39(9):562-5. PubMed ID: 15606009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
    Jones AS; Fish B; Fenton JE; Husband DJ
    Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
    Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
    Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709.
    Agrawal A; Moon J; Davis RK; Sakr WA; Giri SP; Valentino J; LeBlanc M; Truelson JM; Yoo GH; Ensley JF; Schuller DE;
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1044-50. PubMed ID: 17938330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathomorphological aspects of transoral resection of hypopharyngeal carcinoma with preservation of the larynx. Patient selection, treatment results].
    Glanz H
    Laryngorhinootologie; 1999 Dec; 78(12):654-62. PubMed ID: 10666691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
    Yücetürk AV; Celik O; Eskiizmir G
    Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinomas of the aryepiglottic fold: therapeutic results and long-term follow-up.
    Spector JG; Sessions DG; Emami B; Simpson J; Haughey B; Fredrickson JM
    Laryngoscope; 1995 Jul; 105(7 Pt 1):734-46. PubMed ID: 7603279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
    Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of laryngeal cancer.
    Bryce DP
    J Otolaryngol; 1979 Apr; 8(2):105-26. PubMed ID: 430578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing tumour relapse after total laryngectomy.
    Nikolaou A; Markou K; Petridis D; Vlachtsis K; Nalbantian M; Daniilidis L
    B-ENT; 2005; 1(1):1-10. PubMed ID: 15999669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic vertical partial laryngectomy.
    Davis RK; Hadley K; Smith ME
    Laryngoscope; 2004 Feb; 114(2):236-40. PubMed ID: 14755197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of treatment of 584 laryngeal cancers at the Ear-Nose-Throat Clinic of Marburg University].
    Glanz H; Kimmich T; Eichhorn T; Kleinsasser O
    HNO; 1989 Jan; 37(1):1-10. PubMed ID: 2917875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer.
    Holsinger FC; Funk E; Roberts DB; Diaz EM
    Head Neck; 2006 Sep; 28(9):779-84. PubMed ID: 16637055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.